Envista Holdings Corp
corporate_fare Company Profile
Envista Holdings Corp (NYSE:NVST) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 12 items for NVST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-10, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 7 rated 8 or above. Recent SEC coverage for NVST spans FWP, 10-Q, 8-K, DEF 14A.
Recent high-impact activity:
- Envista Prices $430M of 6.250% Senior Notes Due 2033 to Repay 2028 Term Loan
- Envista 10-Q Details Q3: $691.5M Sales, $508.3M GAAP Income Inflated by $428.1M Non-Cash FX Gain
- Envista Tops Q3 Estimates, Lifts FY26 EPS Guidance to $1.54-$1.58
- Envista Lifts 2026 Guidance as Q3 Buyback and Cash Flow Details Emerge
- Envista Posts 3Q Adjusted EPS of 40 Cents
Financial Snapshot
Short Interest & Short Volume
2.95 days to coverFINRA reported short interest of 9,728,394 shares in NVST as of the October 30, 2026 settlement, a 0.5% decrease from the prior period — about 3.0 days to cover at its recent average daily volume. On November 20, 2026, 63.5% of NVST volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for NVST, detected from its recent SEC filings.
Universal Shelf Registered · No Terms, No Proceeds Yet
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →